Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- María Teresa Álvarez, MD
Hospital General Universitario La Paz
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Federal Research Clinical Centre of Pediatric Hematology, Oncology and Immunology Roszdrava
Moscow, Russia
- Haematology Research Centre of Russian Academy of Medical Science
Moscow, Russia
- Hospital General Vall D´hebron
Barcelona, Spain
- . Hospital de León
León, Spain
- Hospital General Universitario la Paz
Madrid, Spain
- Hospital Universitario la Fe
Valencia, Spain
- Hillingdon Hospital
Middlesex, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 31 Dec 2013
- Completion
- 31 Dec 2013
- Last update posted
- 8 Feb 2016
- Registered enrollment
- 18
- Registry id
- NCT00699140
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.